Canada markets closed

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.6900-0.0400 (-1.47%)
At close: 04:00PM EDT
2.8400 +0.15 (+5.58%)
After hours: 06:50PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 491.88M
Enterprise Value 367.64M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)24.98
Price/Book (mrq)4.64
Enterprise Value/Revenue 20.27
Enterprise Value/EBITDA -5.18

Trading Information

Stock Price History

Beta (5Y Monthly) 2.09
52-Week Change 35.49%
S&P500 52-Week Change 323.57%
52 Week High 33.2900
52 Week Low 31.6900
50-Day Moving Average 32.7552
200-Day Moving Average 32.2796

Share Statistics

Avg Vol (3 month) 31.4M
Avg Vol (10 day) 3752.15k
Shares Outstanding 5180.18M
Implied Shares Outstanding 6180.18M
Float 8115.8M
% Held by Insiders 123.34%
% Held by Institutions 143.44%
Shares Short (Apr 15, 2024) 45.17M
Short Ratio (Apr 15, 2024) 42.58
Short % of Float (Apr 15, 2024) 43.69%
Short % of Shares Outstanding (Apr 15, 2024) 42.87%
Shares Short (prior month Mar 15, 2024) 44.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov 04, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-956.64%

Management Effectiveness

Return on Assets (ttm)-28.70%
Return on Equity (ttm)-59.99%

Income Statement

Revenue (ttm)18.14M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)-65.70%
Gross Profit (ttm)N/A
EBITDA -76.63M
Net Income Avi to Common (ttm)-72.85M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)126M
Total Cash Per Share (mrq)0.7
Total Debt (mrq)8.72M
Total Debt/Equity (mrq)8.23%
Current Ratio (mrq)5.87
Book Value Per Share (mrq)0.62

Cash Flow Statement

Operating Cash Flow (ttm)-85.94M
Levered Free Cash Flow (ttm)-51.58M